Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
6 December 2013
Header
Header image
Highlight of the week

Highlight of the week

Global Health Initiatives: Final Report Launch Event
05 December 2013

On December 3, EFPIA launched the final report summarising the outcomes of the Global Health Initiative, a project established with the aim of exploring collaborative, dialogue-driven solutions to global health issues. This was accomplished through a series of public debates, each bringing together diverse stakeholders to discuss global health issues. "The Global Health Initiative: Recommendations from Public Debates" covers the outcomes of these debates and provides recommendations for next steps.

From our blog

From our blog

Welcoming the Global Health Initiative Final Report - Not the Final Word
05 December 2013 by Richard Bergström

Yesterday saw the publication of the final report summarising the outcomes of the Global Health Initiative, a series of public debates that brought together diverse [...] Read more

From our blog

Delivering on our Data Sharing commitments
06 December 2013 by Richard Bergström

As many of you will know there has been a very lively debate over the last year on clinical trials data sharing and how best [...] Read more

Documents

From our blog

EFPIA LIVE WEBINAR - “How pharmaceutical companies are preparing to make clinical data more systematically available”
06 December 2013 (Reports & Studies)

    On 2 December, the European Federation of Pharmaceutical Industries and Associations (EFPIA) hosted a webinar on the implementation of industry’s Principles on clinical trial data [...] Read more

From our blog

The Global Health Initiative: Recommendations from Public Debates
05 December 2013 (Reports & Studies)

Global health is changing rapidly. As global markets and global health become more integrated, unique challenges are presenting themselves. EU policy has to adapt to [...] Read more

What we are reading

What we are reading

$12 Billion Is Pledged to Fight AIDS, TB and Malaria
05 December 2013

The world’s donor countries on Tuesday pledged $12 billion over three years to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The amount was more than the fund took in at its last pledge conference in 2010, but less than the $15 billion it had hoped for. And it is far short of the ambitious goal of $10 billion a year set when the fund was created in 2002.

Read more

What we are reading

World AIDS Day 2013 – Revised guidance to facilitate development of new medicines
05 December 2013

The European Medicines Agency plays a key role in the authorisation of medicines to treat human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS). All antiretroviral medicines in the European Union (EU) have to be authorised centrally at European level, rather than in each Member State separately. This aims to allow the rapid availability of the medicines across the EU.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail